Set to take place in Amsterdam, the Netherlands, from 11 to 14 October 2025, the 38th Congress of the European College of Neuropsychopharmacology (ecnp) is an upcoming event. It brings together around 7,000 professionals from over 100 countries, including psychiatrists, neuroscientists, neurologists, and psychologists. The congress serves as a dynamic platform for sharing the latest developments in brain science, from foundational research to clinical application. The main goal of ECNP 2025 is to highlight the latest advancements in research, treatment strategies, and emerging technologies in the field of brain disorders. The scientific programme covers a wide range of topics related to human mood, cognition, behaviour, and emotion.
The primary aim of the ECNP 2025 is to highlight cutting-edge advancements in research, treatment strategies, and emerging technologies in the realm of brain disorders. The scientific programme encompasses a broad spectrum of topics related to human mood, cognition, behaviour, and emotion.